4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001643071-26-000004
Director sold 6,000 shares at $32.00 ($192,000)
- Director acquired 6,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pande Atul Director | 2026-05-20 | Option exercise 10b5-1 | +6,000 | $8.43 | $50,580 | 122,731 | D |
| Pande Atul Director | 2026-05-20 | Sale 10b5-1 | −6,000 | $32.00 | $192,000 | 116,731 | D |
| Derivatives | |||||||
| Pande Atul Director | 2026-05-20 | Option exercise · Stock Option (right to buy) 10b5-1 | −6,000 | 270,252 | D | ||
| Open-market sales · 6,000 sh · avg $32.00 · $192,000 | |||||||
Loading xslF345X06/wk-form4_1779326521.xml…